Skip to main content
Premium Trial:

Request an Annual Quote

BioServe, Suracell Team on Personal Genomics Testing

NEW YORK (GenomeWeb News) – Genetic testing firm BioServe and personal genomics company Suracell said today that they have struck a partnership for DNA testing services.
 
Under the terms of the agreement, BioServe will serve as Suracell’s exclusive DNA testing partner.
 
BioServe will receive samples collected from de-identified patients who use Suracell’s “genetic testing web portal” program and will analyze the patient DNA using a panel of proprietary SNPs selected by Suracell. BioServe will then transmit the processed data back to Suracell using Suracell’s IT platform, and Suracell will deliver the results to requesting physicians and healthcare practitioners.
 
BioServe said that Suracell’s web portal allows physicians and healthcare centers to order and receive tests and test results online in various formats.
 
The companies hope to expand their agreement into a more “comprehensive partnership” in the future, BioServe said.
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.